Plain-English translation of NCT06539182 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether , a new experimental medication, can help treat chronic lymphocytic leukemia and small lymphocytic lymphoma (types of blood cancers) in people whose disease has come back or is no longer responding to prior treatments. Researchers will give this medication to about 155 patients at different doses to see how well it works and what side effects might occur. The study will also measure how much of the medication stays in your body over time.
Many patients with these blood cancers find that treatments stop working over time, leaving them with limited options. This trial exists to see if this medication could offer a new, effective choice for people in that situation.
You likely qualify if…
You likely don't qualify if…
You would take a daily pill of the medication at home at one of three dose levels being tested. The study involves regular visits to the research center where staff will check your health, take blood samples to measure how the medication is working and what's in your bloodstream, and monitor for any side effects. The study will continue as long as the medication is helping you and you're tolerating it well.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China